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Introduction
Coinfection of single host cells by multiple virions is
common in many viruses (/6: Turner et al. 1999; hepati-
tis B: Bollyky et al. 1996; HIV: Dang et al. 2004; Jetzt
et al. 2000; Levy et al. 2004; Robertson et al. 1995; noro-
virus: Rohayem et al. 2005; measles: Schierup et al. 2005;
VEEV: Smith et al. 2008) and can affect disease outcome
in numerous ways. Perhaps the most signiﬁcant conse-
quences of coinfection have been the recombinant viral
genomes that are produced when a single host is infected
by two very different viral genotypes. Reassortment
between human and animal inﬂuenza has repeatedly
given rise to inﬂuenza pandemics (Cox and Subbarao
2000), recombinant HIV virions have proven capable of
evading drug treatments (Kellam and Larder 1995; Mou-
touh et al. 1996) and immune responses (Streeck et al.
2008), and recombination between wild enteroviruses and
polio vaccine strains has given rise to polio outbreaks
(reviewed by Kew et al. 2005). In addition to recombina-
tion, coinfection allows functional interactions between
virus genotypes within the same cell, and these interac-
tions often lead to a direct or evolved increase in viru-
lence. For example, host cells persistently infected with
defective HIV virions can become highly pathogenic upon
coinfection with a competent virus (Iwabu et al. 2006).
These potentially extreme consequences of coinfection for
viral disease and evolution merit a closer examination of
the conditions under which coinfection is likely to occur.
From the perspective of the virus, coinfection generates
both costs and beneﬁts (Turner and Duffy 2008). Coin-
fection imposes a direct cost in the loss of shared host
resources (Delbru ¨ck 1945; Doermann 1948), as well as an
indirect cost in the evolution of phenotypes that increase
success during coinfection but decrease ﬁtness in single
infections (Turner and Chao 1998). Coinfection also
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Abstract
Two or more viruses infecting the same host cell can interact in ways that
profoundly affect disease dynamics and control, yet the factors determining
coinfection rates are incompletely understood. Previous studies have focused
on the mechanisms that viruses use to suppress coinfection, but recently the
phenomenon of enhanced coinfection has also been documented. In the experi-
ments described here, we explore the hypothesis that enhanced coinfection
rates in the bacteriophage /6 are achieved by virus-induced upregulation of
the /6 receptor, which is the bacterial pilus. First, we conﬁrmed that coinfec-
tion enhancement in /6 is virus-mediated by showing that /6 attaches signiﬁ-
cantly faster to infected cells than to uninfected cells. Second, we explored the
hypothesis that coinfection enhancement in /6 depends upon changes in the
expression of an inducible receptor. Consistent with this hypothesis, the closely
related phage, /12, that uses constitutively expressed lipopolysaccharide as its
receptor, attaches to infected and uninfected cells at the same rate. Our results,
along with the previous ﬁnding that coinfection in /6 is limited to two virions,
suggest that viruses may closely regulate rates of coinfection through mecha-
nisms for both coinfection enhancement and exclusion.
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which may enhance ﬁtness. Genetic exchange can increase
the speed of adaptation by bringing adaptive gene com-
plexes together (Fisher 1930; Muller 1932) and halting the
deleterious action of Muller’s ratchet (Muller 1964), while
complementation can mask the ﬁtness effects of deleteri-
ous mutations (Mindich et al. 1985; Cicin-Sain et al.
2005).
Given that the costs of coinfection increase more
rapidly than the beneﬁts as number of coinfecting part-
ners increases, it is not surprising that viruses have
evolved mechanisms that limit the number of viruses that
coinfect a cell. These superinfection exclusion mecha-
nisms have been observed in multiple viruses, including
the T-even bacteriophages (Dulbecco 1952; Anderson and
Eigner 1971), phiX174 (Vanderavoort et al. 1984), lambda
(Ptashne 2004) and HIV (Michel et al. 2005), and may
be mediated by virus-induced changes in host cells that
inhibit injection (Lesley et al. 1951), cause degradation
(Hershey et al. 1954), or repress replication (Vander-
avoort et al. 1984; Ptashne 2004) of the genomes of
superinfecting viruses, or that reduce the expression of
virus receptors on the cell surface (Marschall et al. 1997;
Breiner 2001; Michel et al. 2005). One important feature
of superinfection exclusion is that it is not manifested
instantaneously, so that viruses that completely block
superinfection may still undergo coinfection if the interval
between entry of coinfecting partners is sufﬁciently small
(Christen et al. 1990). As a result, when virus densities
are high (i.e. the interval between infections is small),
coinfection should be common in spite of superinfection
exclusion.
In contrast, when coinfection rates are low, as expected
when virus densities in the environment or in a multicel-
lular host are low, the ability to enhance coinfection may
confer a selective advantage. It has recently been observed
in HIV (Dang et al. 2004), Venezuelan equine encephalitis
(Smith et al. 2008), human cytomegalovirus (Cicin-Sain
et al. 2005), and the bacteriophage /6 (Turner et al.
1999), that the frequency of individual host cells
coinfected with two marked genotypes is higher than
expected if viruses infect cells at random. These studies
suggest that a subpopulation of host cells are particularly
susceptible to virus infection, however, they do not dis-
tinguish the mechanism by which variation in host cell
susceptibility arises. Differences in susceptibility could
result from inherent physiological differences among host
cells that existed prior to infection, or from physiological
differences that are induced by virus infection. Distin-
guishing between these mechanisms would shed light on
the potential for virus-mediated coinfection enhancement.
The current study was motivated by Turner et al.’s
(Turner et al. 1999) anecdotal ﬁnding that coinfection
frequencies are enhanced in /6 bacteriophage. We inves-
tigated the mechanism for this enhancement, focusing on
the hypothesis that infection triggers increased surface-
expression of pilus (the /6 receptor), thereby increasing
the likelihood of coinfection. This hypothesis seemed
plausible because surface-expression of pilus is facultative
and known to change in response to environmental cues
(Merz et al. 2000). Speciﬁcally, we tested two predictions
of this hypothesis: (i) /6 infection or attachment will
result in enhanced attachment of subsequent viral parti-
cles and (ii) enhanced attachment will not occur in phage
that utilize constitutively expressed lipopolysaccharide as
a receptor. As described below, both predictions were
supported, suggesting that /6 coinfection is enhanced by
upregulation of pilus expression in infected bacterial
hosts.
Materials and methods
Strains and cultures conditions
The double-stranded RNA bacteriophages /6 (Vidaver
et al. 1973) and /12 (Mindich et al. 1999) were used in
this study. /6 and /12 use as their receptor the host
pilus (Vidaver et al. 1973; Bamford et al. 1976, 1987),
and lipopolysaccharide (LPS) (Mindich et al. 1999),
respectively. The /6 strain used in this study was recon-
structed from cloned genome segments (Gottlieb et al.
1992) of a wildtype /6 isolate (Vidaver et al. 1973).
Leonard Mindich (Public Health Research Institute of
New Jersey Medical School) generously supplied the
plasmids and bacteria used to assemble /6 and supplied
an isolate of /12.
Bacteriophages and their hosts were cultured and
titered in standard LC media (5 g yeast extract, 5 g NaCl,
and 10 g Bacto-tryptone per liter H2O) (Burch and Chao
1999). Phages were grown on plates by overlaying a mix-
ture of phage, bacteria, and top agar (LC + 0.7% agar)
onto solid media (LC + 1.5% agar). /6 bacteriophage
were cultured with their standard host Pseudomonas
syringae pathovar phaseolicola strain HB10Y, which was
obtained from the American Type Culture Collection
(ATCC no. 21781). /12 bacteriophage were cultured on
LM2333 bacteria obtained from Leonard Mindich.
LM2333 is a mutant of HB10Y and is thought to produce
rough LPS which facilitates /12 binding (Mindich et al.
1999).
Attachment rate
We performed three experiments using the following gen-
eral protocol to measure the rate that bacteriophage
attach to host bacteria. First, bacteriophage were mixed
with exponentially growing bacteria that had achieved a
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8 cells/mL. Initial phage
(P0) and bacteria (N0) densities were determined by plat-
ing. Phage and bacteria were then mixed and incubated
for t = 55 or 60 min at 25 C with continuous shaking.
At the end of the incubation period, the density of
free phage (Pt) was again determined by plating and
attachment rate (k) was calculated as:
k ¼ lnðP0=PtÞ=ðN0tÞð 1Þ
Statistical analyses
Standard analyses were performed using JMP statistical
software (version 6.0.3, SAS Institute, Cary, NC) and the
model selection analysis was performed using R statistical
software (version 2.6.2).
Results
Preferential attachment to infected bacteria
The previous ﬁnding that coinfection rates in /6 are
higher than expected if hosts are equally susceptible to
infection (Turner et al. 1999) can be explained by two
different scenarios: (i) uninfected bacteria differ in their
susceptibility to infection, or (ii) an initial infection
increases the susceptibility of a bacterium to subsequent
infection. We ﬁrst investigated whether attachment rate
was affected by the infection status of the bacteria. If
infection modiﬁes host cells in ways that cause other
viruses to attach to them more quickly, then we predict
that attachment rates will be the highest in populations
containing a high proportion of infected host cells and
the lowest in populations with few infected cells.
We tested this hypothesis by measuring attachment
rates in populations with different ratios of viruses to
hosts (i.e. different multiplicities of infection or MOIs)
and, therefore, different proportions of infected cells
(Fig. 1A). This was achieved by incubating 43 densities of
/6 bacteriophage, ranging from 2.8 · 10
6 to 1.8 · 10
9
/6/ mL, with HB10Y bacteria at a density of 7.7 · 10
7
(±3.8 · 10
7) cells/ mL for 60 min. The results of these
experiments (Fig. 1A) indicate that attachment rate
depends on MOI, but they do not show the highest
attachment rates in the highest MOI populations. Rather,
the data were best described by a second order polyno-
mial (AIC score of second order polynomial = )2014 and
AIC score of linear model = )2002.8), with maximum
attachment rates in populations with intermediate MOI
values (Fig. 1A; R
2 = 0.34, F2,40 = 10.28, P = 0.0003).
The second order polynomial that gave the best ﬁt to
the data supported a model of enhancement by showing
that attachment rates were higher at intermediate MOIs
than at low MOIs. However, the observed curvilinearity
resulted primarily from the drop in attachment rates at
high MOIs. In fact, the decrease in attachment rate at
high MOIs would have been enough to generate a similar
polynomial even if attachment rate was similar among
low and intermediate MOIs. We conﬁrmed that attach-
ment rate is higher at intermediate than at low MOI by
measuring attachment rates with a high level of replica-
tion at one low MOI and one intermediate MOI. In the
low MOI assays, 12 replicates containing 1 · 10
7 /6 bac-
teriophage were incubated with 4.5 · 10
8 cells of HB10Y
in 1 mL LC for 55 min (log MOI = )1.65, proportion of
infected cells = 4%) and in the intermediate MOI assays,
12 replicates of 5.5 · 10
8 /6 bacteriophage were incu-
bated with 2.7 · 10
8 cells of HB10Y for the same time
period (log MOI = 0.3, proportion of infected cells =
63%). Consistent with our initial predictions, the inter-
mediate MOI populations had a signiﬁcantly higher mean
Figure 1 Preferential attachment to infected cells. (A) The relationship between the rate that /6 attach to their bacterial host and log MOI as
estimated from forty-three attachment assays. This relationship is described by a second order polynomial (R
2 = 0.34; P = 0.0003). (B) Attachment
rate estimates based on twelve attachment assays performed at each of two log MOIs. Attachment rates are signiﬁcantly higher in intermediate
MOI populations where infection is common than in low MOI populations where infection is rare (t-test; P < 0.0001).
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F1,22 = 345.6, P < 0.0001) .
In these attachment rate experiments we used MOI as
a proxy for the proportion of infected cells. In order to
make the relationship between these values more explicit,
we calculated the proportion of infected cells in the 43
replicate populations examined in the ﬁrst attachment
rate experiment. The proportion of infected cells can be
expressed as the Poisson probability that a cell is infected
by one or more bacteriophage, given the total number of
bound phages (Pbound) and the total number of bacteria
(N0):
PrðinfectedÞ¼1   e Pbound=N0 ð2Þ
Pbound can then be calculated as a theoretical expecta-
tion, given a particular attachment rate k, phage density
P0, and bacterial density N0:
Pbound ¼ P0ð1   e kN0tÞð 3Þ
Or, Pbound can be determined empirically by subtract-
ing the measured number of free (unbound) phages at
60 min from the initial measure at 0 min:
Pbound ¼ P60   P0: ð4Þ
We used the average bacterial density measured in this
experiment (7.7 · 10
7 bacteria/ mL) and the attachment
rate measured at log(MOI) = 0.3 (k = 1.4 · 10
)10)t o
determine the theoretical expectation. We then show both
the expectation and the experimentally determined rela-
tionship between MOI and the proportion of infected
cells in Fig. 2. The empirically determined probabilities
show an excellent ﬁt to the expectation, deviating mainly
because of measurement error in our estimates of bacte-
rial and phage densities.
There was good correspondence between the range of
MOIs over which the proportion of infected cells shifted
from few to many and the range of MOIs over which
attachment rates shifted from increasing to decreasing.
Pilus-mediated coinfection enhancement
We further examined the relationship between coinfection
enhancement in /6 and the use of host pilus as the phage
receptor by comparing the effect of infection on attach-
ment rate in /6 and its close relative /12. We made this
comparison because /6 uses the facultatively expressed
(Roine et al. 1996) host pilus as its receptor (Bamford
et al. 1987; Gottlieb et al. 1988), while /12 binds to host
LPS (Mindich et al. 1999) which is constitutively
expressed (Whitﬁeld and Valvano 1993). If the ultimate
cause of coinfection enhancement is upregulation of
bacteriophage receptor, then viruses such as /6 – whose
receptor is inducible – will be capable of enhancement,
while viruses such as /12 – whose receptor is constitu-
tively expressed – will be incapable of enhancement.
We supported this hypothesis using 32 assays examin-
ing the rate that /12 attach to their bacterial host over
a range of MOIs. These attachment assays were per-
formed by incubating 32 densities of /12 bacteriophage,
ranging from 6.7 · 10
6 to 8.7 · 10
8 /12/ mL, with
LM2333 bacteria at a density of 1.2 · 10
8 (±8.5 · 10
7)
cells/ mL for 60 min. The results of these assays indicate
that there is no relationship between attachment rate
and log MOI in /12 (Fig. 3; R
2 = 0.02, F1,30 = 0.72,
P = 0.40) . Therefore, the rate that /12 phage attach to
host cells does not depend on the proportion of cells
that are infected.
Discussion
Turner et al.’s (Turner et al. 1999) ﬁnding that coinfec-
tion rates are enhanced in /6 strongly suggests that host
cells differ in their susceptibility to infection – with the
most susceptible cells being infected by multiple virions.
In the current study we test this possibility and examine
whether differences in host susceptibility arise from inher-
ent physiological differences that existed prior to infection
or physiological differences that are induced by virus
Figure 2 Proportion of host cells infected. The expected relationship
between the proportion of infected host cells and log MOI is esti-
mated using equations 2 and 3 (shown as a line). Each point is the
experimentally determined proportion of infected cells in one of 43
replicate attachment assays (Fig. 1A), calculated using equations 2
and 4. The action of a superinfection exclusion mechanism in /6i s
suggested by the correspondence between the range of MOIs over
which the proportion of infected cells shifted from few to many and
the range of MOIs over which attachment rates shifted from increas-
ing to decreasing (Fig. 1A).
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riophages attach signiﬁcantly faster in host populations
containing a larger proportion of infected hosts, we con-
ﬁrm that hosts can differ in their susceptibility to infec-
tion and that these susceptibility differences are induced
by virus attachment or infection. These results represent
the ﬁrst demonstration that coinfection enhancement can
be virus mediated.
We also investigated the mechanism by which /6
enhances the likelihood of coinfection. Viruses that sup-
press superinfection frequently do so by downregulating
the host receptor (Marschall et al. 1997; Breiner 2001;
Michel et al. 2005); we therefore reasoned that upregula-
tion of the /6 receptor – the host pilus (Vidaver et al.
1973; Bamford et al. 1976, 1987; Roine et al. 1996) –
could enhance coinfection by making host cells more
susceptible to infection. We also reasoned that a related
bacteriophage, /12, whose receptor (LPS (Mindich et al.
1999)) is constitutively expressed (Whitﬁeld and Valvano
1993) should be incapable of enhancing coinfection. Our
observation that /6, but not /12, bacteriophage attach at
a higher rate in populations with a higher proportion of
infected hosts is consistent with these predictions and
suggests the following model of coinfection enhancement
in /6. (i) A /6 bacteriophage attaches to a host pilus and
infects the host cell. (ii) Events during phage attachment
or infection cause pilus extension to be favored over pilus
retraction. (iii) Pilus extension exposes additional phage
attachment sites, thus increasing the rate that bacterio-
phage attach to infected hosts. This model is consistent
with the major observations of our study, and provides
direction for future investigations into the timing and
type of modiﬁcations made to host cells.
It is worth noting that the data cannot be fully
explained by the simplest version of this model in which
pilus retraction is simply turned off. Although turning off
pilus retraction could result in higher attachment rates, it
could not result in enhanced coinfection because pilus
retraction is a required step for phage infection of the
host cell. In this simple model, the only remaining expla-
nation for the previous observation of enhanced coinfec-
tion in /6 (Turner et al. 1999) is that a substantial subset
of host cells are uninfectable. However, in our hands
>99.5% of hosts become infected in the high MOI condi-
tions used here and in Turner et al. (Turner et al. 1999)
(data not shown). Thus, our observations of enhanced
coinfection and infection-induced increases in attachment
rate are best explained by a more complex model
in which phage infection shifts the balance in favor of
pilus extension, but does not completely prevent pilus
retraction.
Although we did not investigate the molecular mecha-
nism responsible for virus-mediated increases in attach-
ment rate in /6, recent studies of pilus-dependent
motility in Neisseria meningitides and N. gonorrhoeae sug-
gest multiple ways to alter the balance between pilus
extension (which exposes attachment sites) and retraction
(which hides attachment sites). In Neisseria, 15 proteins
are required for pilus extension and retraction (Carbonn-
elle et al. 2005), some of which must be actively synthe-
sized during those processes (Merz et al. 2000). Further,
both processes require ATP binding and hydrolysis
(Jakovljevic et al. 2008). These results suggest that bacte-
riophage attachment rates may ﬂuctuate due to changes
in the expression of proteins mediating pilus extension
and retraction or due to changes in bacterial kinetics that
make one of these processes more energetically favorable
than the other.
One observation that our model of coinfection
enhancement does not predict is the decline in attach-
ment rate that we observed at high MOIs (Fig. 1A). One
possible explanation is that at very high MOIs phage
binding sites on the pilus become saturated with phage.
However, attachment rate begins to decline at an MOI
of around two phages per host cell – too few to achieve
saturation. A more likely explanation for the decline in
attachment rate may be the engagement of a pilus-medi-
ated superinfection exclusion mechanism that prevents
more than two phages from infecting the cell. Indeed, we
already know that coinfection in /6 is limited to two
phages per cell (Turner et al. 1999). Although speculative,
this explanation is intriguing because it would require
that pilus expression is under sufﬁciently ﬁne control that
infection by one phage favors pilus extension, whereas
Figure 3 Pilus-mediated coinfection enhancement. Thirty-two assays
were performed to estimate the rate that /12 bacteriophage attach
to their bacterial host over different MOIs. There was no signiﬁcant
relationship between attachment rate and log MOI (R
2 = 0.01;
P = 0.47), indicating that /12 bacteriophage do not enhance coinfec-
tion rates by preferentially attaching to infected bacteria.
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more, by acting together to generate host cells infected by
exactly two phages, coinfection enhancement and superin-
fection exclusion would maximize the net beneﬁts of
coinfection.
Causes of variation in virus coinfection rates
The ﬁnding of coinfection enhancement in only a few
viruses (HIV (Dang et al. 2004), VEEV (Smith et al.
2008), HCMV (Cicin-Sain et al. 2005), and /6 (Turner
et al. 1999)) in comparison to the near ubiquity of mech-
anisms for superinfection exclusion (Delbru ¨ck and Luria
1942; Dulbecco 1952; Anderson and Eigner 1971) leads
one to question what aspects of virus biology sets coinfec-
tion enhancers apart from other viruses? Although the
apparent rarity of coinfection enhancement may have
resulted simply because this phenomenon is more difﬁcult
to observe than superinfection exclusion, there are both
mechanistic and evolutionary reasons to expect viruses to
differ in the use and strength of enhancement versus
exclusion mechanisms.
Mechanistically, the relative abundance of superinfec-
tion exclusion, as compared to enhancement, may occur
because there are a greater number of mechanisms by
which viruses can achieve superinfection exclusion. While
individual virus species may experience constraints that
prevent the use of any particular exclusion mechanism,
they are likely to possess the ability to evolve at least one
mechanism. In contrast, enhancement has been observed
to occur only via an increase in expression of virus recep-
tor on the host cell surface (Chen et al. 2005) or via a
cell-mediated pathway in which dendritic cells or mono-
cytes/macrophages capture and transmit multiple virions
to a target cell (Chen et al. 2005; Cicin-Sain et al. 2005).
These results suggest that viruses may differ in their abil-
ity to enhance coinfection simply based on the type of
receptor they use or whether they have cell-mediated
infection.
Alternatively, populations could differ in the costs and
beneﬁts associated with coinfection, causing natural selec-
tion to favor different responses to infection and coinfec-
tion in different populations. First, viruses may differ
intrinsically in ways that affect the beneﬁts (or costs) of
coinfection. For example, some viruses, such as HIV and
/6, have mechanisms like polymerase switching (Cofﬁn
1979) and segmentation (Vidaver et al. 1973) that allow
them to frequently recombine/reassort during coinfection,
whereas other viruses, such as some ﬂaviviruses rarely, if
ever, recombine (Monath et al. 2005). If the primary
advantage of coinfection is recombination/reassortment
then viruses lacking such mechanisms will receive little
beneﬁt from coinfection. Second, virus and host ecology
will have a direct effect on the realized costs and beneﬁts
of coinfection. Phage in environments with higher ratios
of phages to hosts should exhibit less coinfection
enhancement. In such environments, there is no need to
enhance coinfection, and moreover, enhancement should
be disfavored if it tends to elevate the number of
coinfecting viruses above two (costs would increase, but
beneﬁts would not).
Returning to our comparison of /6 and /12, we pro-
posed the following mechanism for their differences in
phage-mediated increases in attachment rate – the use of
a constitutively expressed receptor prevents /12 from
evolving coinfection enhancement. However, our data do
not rule out the possibility that ecological differences in
the natural environment of these phages favored coinfec-
tion enhancement in /6 but not in /12. The nature of
the difference between these two phages raises the intrigu-
ing possibility of distinguishing between these mechanistic
and evolutionary hypotheses in future laboratory evolu-
tion experiments that manipulate host and virus ecology
to impose selection either for coinfection enhancement or
coinfection inhibition.
Implications of coinfection enhancement for disease
management
Coinfection enhancement poses a challenge to disease
management due to its ability to generate recombination
in populations where virus densities are kept low by sup-
pression mechanisms. In any scenario in which two (or
more) mutations are required for escape from suppres-
sion, the small size of suppressed virus populations makes
it unlikely that an escape double mutant will evolve de
novo or be generated by recombination between viruses
carrying different escape mutations. This type of recombi-
nation event would be possible, however, if the virus was
capable of coinfection enhancement. Here we discuss how
coinfection enhancement may promote such rare recom-
bination events.
We can think of three scenarios in which viral densities
are suppressed to the point where coinfection is unlikely
and where two or more mutations are needed to escape
from suppression. In the ﬁrst scenario, virus titers are
suppressed by antiviral drugs, and the use of multiple
drug therapies ensures that viruses need to simultaneously
acquire multiple drug resistance mutations. Under these
conditions, coinfection enhancement could speed the evo-
lution of multi-drug resistance by facilitating recombina-
tion between viruses carrying different resistance alleles.
Similarly, virus titers could be kept low by partial host
immunity, either via natural immunity or imperfect
vaccines (Gandon et al. 2001). In this second scenario,
coinfection enhancement has the potential to facilitate
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In the third scenario, hosts are vaccinated with live, atten-
uated viruses whose densities remain too low to cause
disease. This last scenario could be particularly problem-
atic because many vaccines are multivalent, containing
multiple virus strains. Attenuated vaccine viruses are
thought to be safe because multiple mutations are
required to make them pathogenic, however, if the strains
contained in a multivalent vaccine are attenuated via dif-
ferent suites of mutations, then recombination could pro-
duce pathogenic viruses by combining mutation-free
genome regions from multiple strains. To minimize this
risk, multivalent vaccines are often comprised of multiple
virus strains attenuated by common mutations. If coinfec-
tion enhancement is a general characteristic of viral
pathogens, then strategies like this one may be critical to
the success of antiviral treatments.
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